The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.

Lymph node Metastasis Staging Thymic carcinoma Thymoma

Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
27 Sep 2023
Historique:
received: 26 07 2023
revised: 06 09 2023
accepted: 21 09 2023
pubmed: 30 9 2023
medline: 30 9 2023
entrez: 29 9 2023
Statut: aheadofprint

Résumé

Stage classification is an important underpinning of management in patients with cancer and rests on a combination of three components-T for tumor extent, N for nodal involvement, and M for distant metastases. This article details the revision of the N and the M components of thymic epithelial tumors for the ninth edition of the TNM classification of malignant tumors proposed by the Thymic Domain of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee. The N and M components of the eighth edition staging system were verified by a large international collaborative data source through a data-driven analysis. A total of 9147 cases were included for analysis, including 7662 thymomas, 1345 thymic carcinomas, and 140 neuroendocrine thymic tumors. Lymph node involvement rates were 1.5% in thymomas and 17.6% and 27.7% in thymic carcinomas and neuroendocrine thymic tumors, respectively. Rates of lymph node metastasis were increasingly higher in tumors with higher T stage and higher-grade histologic type. Survival analysis validated the differences in the N and M categories proposed in the eighth edition staging system. Good discrimination in overall survival was detected among pathologic (p)N and pM categories in patients with thymoma and thymic carcinoma. No changes are proposed from the eighth edition for the N and M components. The proposed stage classification will provide a useful tool for management of the disease among the global thymic community.

Identifiants

pubmed: 37774950
pii: S1556-0864(23)02257-8
doi: 10.1016/j.jtho.2023.09.1447
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 International Association for the Study of Lung Cancer. All rights reserved.

Auteurs

Wentao Fang (W)

Shanghai Chest Hospital, Jiaotong University Medical School, Shanghai, People's Republic of China.

Nicolas Girard (N)

Institut Curie, Paris, France.

Vanessa Cilento (V)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Emily Goren (E)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Daniel Dibaba (D)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Enrico Ruffini (E)

University of Torino, Torino, Italy. Electronic address: enrico.ruffini@unito.it.

Usman Ahmad (U)

Thoracic Surgery in the Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

Sarit Appel (S)

Sheba Medical Center, Ramat Gan, Israel.

Andrea Bille (A)

Guy's Hospital, London, United Kingdom.

Souheil Boubia (S)

University Hospital Ibn Rochd, Casablanca, Morocco.

Cecilia Brambilla (C)

Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

Ayten Kayi Cangir (AK)

Ankara University Faculty of Medicine, Ankara, Turkey.

Frank Detterbeck (F)

Yale University School of Medicine, New Haven, Connecticut.

Conrad Falkson (C)

Queen's University at Kingston, Ontario, Canada.

Pier Luigi Filosso (PL)

Baggiovara Civil Hospital, University of Modena, Modena, Italy.

Giuseppe Giaccone (G)

Meyer Cancer Center, Weill-Cornell Medicine, New York, New York.

Francesco Guerrera (F)

University of Torino, Torino, Italy.

James Huang (J)

Memorial Sloan Kettering Cancer Center, New York, New York.

Maurizio Infante (M)

University and Hospital Trust, Verona, Italy.

Dong Kwan Kim (DK)

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Marco Lucchi (M)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Mirella Marino (M)

IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Edith M Marom (EM)

Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.

Andrew G Nicholson (AG)

Royal Brompton and Harefield NHS Hospitals, Guy's and St. Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, United Kingdom.

Meinoshin Okumura (M)

National Hospital Organization Osaka Toneyama Medical Center, Osaka, Japan.

Ramon Rami-Porta (R)

Hospital Universitari Mutua Terrassa, Terrassa, Spain, and Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.

Andreas Rimner (A)

Memorial Sloan Kettering Cancer Center, New York, New York.

Charles B Simone (CB)

Memorial Sloan Kettering Cancer Center, New York, New York.

Hisao Asamura (H)

Keio University, Tokyo, Japan.

Classifications MeSH